Concept confirmation of the Schizophrenia Cognition Rating Scale (SCoRS) among unpaid and professional caregivers

Schizophrenia is a complex mental health condition characterized by a range of heterogenous symptoms. Cognitive impairment associated with schizophrenia (CIAS) interferes with individuals' ability to manage their daily activities and has a detrimental effect on everyday life. The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment, which was developed to provide a detailed evaluation of the performance of everyday tasks in the real world. The assessment is completed by clinicians with input from patients with schizophrenia and caregivers. The scale has good psychometric properties and has been used across several trials. Nevertheless, the relevance of the SCoRS from the caregivers' perspective has not been confirmed. The aim of this study was to confirm the content of the SCoRS from the caregivers' perspective. A cross-sectional qualitative study was conducted with primary (live-in, for example, a family member) and secondary (professionally trained) caregivers in the US caring for patients with schizophrenia. The caregiver research confirmed the concepts that clinicians and patients had previously identified in the creation of the PRECIS scale as clear cognitive deficits of patients with schizophrenia. Understanding that family and professional caregivers confirm these cognitive impairments to be real, independently from the patient and clinicians, is helpful to determine the validity of the cognitive impairment concept. Overall, the findings confirmed that the SCoRS captures relevant aspects of cognitive functioning in patients with schizophrenia and support the relevance and clarity of instructions, domains, and items with primary and secondary informants.

Authors

Institutions

Publication Details

Journal
Schizophrenia
Published
2025-10-17
DOI
https://doi.org/10.1038/s41537-025-00674-2
Citations
1
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Concept confirmation of the Schizophrenia Cognition Rating Scale (SCoRS) among unpaid and professional caregivers

Richard S.E. Keefe, K. Rüdell, Alessandra Girardi, Abraham Goldring et al.
1 citations
Schizophrenia
Schizophrenia research and treatment
1.47
article

Concept confirmation of the Schizophrenia Cognition Rating Scale (SCoRS) among unpaid and professional caregivers

Richard S.E. Keefe, K. Rüdell, Alessandra Girardi, Abraham Goldring, Christoph Ulrich Correll, Corey Reuteman-Fowler, Maggie Heinrich, Sébastien Tulliez
article en
1 citations

Abstract

Schizophrenia is a complex mental health condition characterized by a range of heterogenous symptoms. Cognitive impairment associated with schizophrenia (CIAS) interferes with individuals' ability to manage their daily activities and has a detrimental effect on everyday life. The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment, which was developed to provide a detailed evaluation of the performance of everyday tasks in the real world. The assessment is completed by clinicians with input from patients with schizophrenia and caregivers. The scale has good psychometric properties and has been used across several trials. Nevertheless, the relevance of the SCoRS from the caregivers' perspective has not been confirmed. The aim of this study was to confirm the content of the SCoRS from the caregivers' perspective. A cross-sectional qualitative study was conducted with primary (live-in, for example, a family member) and secondary (professionally trained) caregivers in the US caring for patients with schizophrenia. The caregiver research confirmed the concepts that clinicians and patients had previously identified in the creation of the PRECIS scale as clear cognitive deficits of patients with schizophrenia. Understanding that family and professional caregivers confirm these cognitive impairments to be real, independently from the patient and clinicians, is helpful to determine the validity of the cognitive impairment concept. Overall, the findings confirmed that the SCoRS captures relevant aspects of cognitive functioning in patients with schizophrenia and support the relevance and clarity of instructions, domains, and items with primary and secondary informants.

SchizophreniaVol. 11(1)
Nathan Kline Institute for Psychiatric Research (US), Northwell Health (US), Feinstein Institute for Medical Research (US), PAREXEL International (United Kingdom) (GB), Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US), Boehringer Ingelheim (Egypt) (EG), Duke Medical Center (US), Boehringer Ingelheim (China) (CN), Boehringer Ingelheim (United States) (US), Zucker Hillside Hospital (US), Charité - Universitätsmedizin Berlin (DE)
Openalex Percentile: Top 14%
Schizophrenia research and treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.